E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/12/2006 in the Prospect News Biotech Daily.

Aksys cash burn down during third quarter, R&D spending up

By Lisa Kerner

Charlotte, N.C., Oct. 12 - Aksys, Ltd. used cash of $4.23 million in operations during the third quarter of 2006, with cash use of $4.75 million estimated for the fourth quarter.

Total cash used in operations for 2006 is expected to be about $19.15 million, a 34% reduction from the previous year.

Aksys expects to use total cash in the range of $18.5 million to $19.5 million for the full-year 2007.

Management expects research and development spending to account for about 63% of cash used in operations in 2007, compared with 48% during the second half of 2006.

.Aksys develops hemodialysis products and services in Lincolnshire, Ill.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.